Y Intercept Hong Kong Ltd Has $3.34 Million Stock Position in Chemed Corporation $CHE

Y Intercept Hong Kong Ltd trimmed its holdings in shares of Chemed Corporation (NYSE:CHE) by 24.1% in the third quarter, according to its most recent filing with the SEC. The firm owned 7,463 shares of the company’s stock after selling 2,374 shares during the period. Y Intercept Hong Kong Ltd’s holdings in Chemed were worth $3,341,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently bought and sold shares of CHE. Sequoia Financial Advisors LLC acquired a new stake in Chemed during the 2nd quarter valued at $342,000. Vontobel Holding Ltd. grew its holdings in Chemed by 44.5% during the 2nd quarter. Vontobel Holding Ltd. now owns 2,821 shares of the company’s stock worth $1,374,000 after acquiring an additional 869 shares during the period. Vest Financial LLC boosted its holdings in Chemed by 32.6% during the third quarter. Vest Financial LLC now owns 9,702 shares of the company’s stock worth $4,344,000 after buying an additional 2,383 shares during the last quarter. Fenimore Asset Management Inc grew its holdings in Chemed by 28.3% during the third quarter. Fenimore Asset Management Inc now owns 37,240 shares of the company’s stock valued at $16,674,000 after purchasing an additional 8,222 shares during the period. Finally, Fort Washington Investment Advisors Inc. OH grew its holdings in shares of Chemed by 45.8% in the 3rd quarter. Fort Washington Investment Advisors Inc. OH now owns 55,979 shares of the company’s stock valued at $25,064,000 after buying an additional 17,587 shares during the period. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Chemed Price Performance

CHE stock opened at $446.72 on Tuesday. Chemed Corporation has a 1 year low of $408.42 and a 1 year high of $623.60. The firm has a market capitalization of $6.33 billion, a P/E ratio of 23.62, a P/E/G ratio of 2.18 and a beta of 0.44. The business’s 50-day moving average is $436.75 and its two-hundred day moving average is $443.04.

Chemed (NYSE:CHE) last released its earnings results on Tuesday, October 28th. The company reported $5.27 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.39 by ($0.12). Chemed had a return on equity of 25.89% and a net margin of 11.02%.The business had revenue of $624.90 million for the quarter, compared to analyst estimates of $626.04 million. During the same quarter in the previous year, the firm posted $5.64 EPS. The business’s revenue for the quarter was up 3.1% on a year-over-year basis. On average, analysts expect that Chemed Corporation will post 21.43 EPS for the current year.

Chemed Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, December 5th. Stockholders of record on Monday, November 17th were given a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date was Monday, November 17th. Chemed’s dividend payout ratio (DPR) is presently 12.69%.

Insider Buying and Selling at Chemed

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction on Monday, November 24th. The stock was sold at an average price of $437.55, for a total transaction of $875,100.00. Following the completion of the transaction, the chief executive officer directly owned 94,197 shares of the company’s stock, valued at approximately $41,215,897.35. The trade was a 2.08% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. 3.29% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several brokerages have issued reports on CHE. Royal Bank Of Canada lowered their price target on Chemed from $589.00 to $572.00 and set an “outperform” rating for the company in a report on Monday, November 10th. Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a research report on Thursday, October 30th. Jefferies Financial Group downgraded shares of Chemed from a “buy” rating to a “hold” rating in a report on Thursday. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Chemed in a report on Wednesday, January 21st. Three research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $555.50.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.